These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11747277

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Paget's disease of bone: five regimens of pamidronate treatment.
    Pepersack T, Karmali R, Gillet C, François D, Fuss M.
    Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
    [Abstract] [Full Text] [Related]

  • 26. Paget's disease of bone: experience from a centre in southern India.
    Anjali, Thomas N, Rajaratnam S, Shanthly N, Oommen R, Seshadri MS.
    J Assoc Physicians India; 2006 Jul; 54():525-9. PubMed ID: 17089899
    [Abstract] [Full Text] [Related]

  • 27. [Prospective study of pamidronate disodium in treatment of Paget's disease of bone].
    Zhang ZL, Meng XW, Xing XP, Wang O, Xia WB, Li M, Jiang Y, Fu Y, Zhou XY.
    Zhonghua Yi Xue Za Zhi; 2003 Oct 10; 83(19):1653-6. PubMed ID: 14642096
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin.
    Yap AS, Mortimer RH, Jacobi JM, Galligan JP, Perry-Keene DA, Khafagi FA.
    Horm Res; 1991 Oct 10; 36(1-2):70-4. PubMed ID: 1814803
    [Abstract] [Full Text] [Related]

  • 32. Short-term intravenous therapy with Neridronate in Paget's disease.
    Adami S, Bevilacqua M, Broggini M, Filipponi P, Ortolani S, Palummeri E, Ulivieri F, Nannipieri F, Braga V.
    Clin Exp Rheumatol; 2002 Oct 10; 20(1):55-8. PubMed ID: 11892710
    [Abstract] [Full Text] [Related]

  • 33. Quantitative bone scintigraphy in the management of monostotic Paget's disease of bone.
    Patel S, Pearson D, Hosking DJ.
    Arthritis Rheum; 1995 Oct 10; 38(10):1506-12. PubMed ID: 7575701
    [Abstract] [Full Text] [Related]

  • 34. Paget's disease of bone: reduction of disease activity with oral risedronate.
    Hosking DJ, Eusebio RA, Chines AA.
    Bone; 1998 Jan 10; 22(1):51-5. PubMed ID: 9437513
    [Abstract] [Full Text] [Related]

  • 35. Bisphosphonate resistance in Paget's disease of bone.
    Joshua F, Epstein M, Major G.
    Arthritis Rheum; 2003 Aug 10; 48(8):2321-3. PubMed ID: 12905487
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
    Scharla SH, Grauer A, Ziegler R.
    Klin Wochenschr; 1991 Jan 04; 69(1):25-30. PubMed ID: 2016845
    [Abstract] [Full Text] [Related]

  • 39. [Paget's disease and its therapeutic management].
    Orcel P, Rousière M.
    Presse Med; 2005 Apr 23; 34(8):612-6. PubMed ID: 15962504
    [Abstract] [Full Text] [Related]

  • 40. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec 23; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.